BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23923974)

  • 1. The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients.
    Hulbert AL; Delahunty AJ; Rajab A; Forbes RC; Winters HA
    Clin Transplant; 2013; 27(4):E521-7. PubMed ID: 23923974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients.
    Knight RJ; Villa M; Laskey R; Benavides C; Schoenberg L; Welsh M; Kerman RH; Podder H; Van Buren CT; Katz SM; Kahan BD
    Clin Transplant; 2007; 21(4):460-5. PubMed ID: 17645704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
    Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center.
    Tan CS; Loh HL; Foo MW; Choong LH; Wong KS; Kee TY
    Clin Transplant; 2013; 27(4):E462-8. PubMed ID: 23682851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials.
    Cooper M; Wiseman AC; Zibari G; McCague K; Kim Y; Geissler F; Nashan B
    Clin Transplant; 2013; 27(6):E625-35. PubMed ID: 24033455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy.
    Sandrini S; Setti G; Bossini N; Maffei C; Iovinella L; Tognazzi N; Maffeis R; Nodari F; Portolani N; Cancarini G
    Clin Transplant; 2009; 23(1):16-22. PubMed ID: 18727661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients.
    Tiong HY; Flechner SM; Zhou L; Wee A; Mastroianni B; Savas K; Goldfarb D; Derweesh I; Modlin C
    Transplantation; 2009 Jan; 87(2):296-302. PubMed ID: 19155988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisone-free maintenance immunosuppression in obese kidney transplant recipients.
    Matas AJ; Vock DM
    Clin Transplant; 2019 Oct; 33(10):e13668. PubMed ID: 31310030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of sirolimus on wound healing in dermatologic surgery.
    Brewer JD; Otley CC; Christenson LJ; Phillips PK; Roenigk RK; Weaver AL
    Dermatol Surg; 2008 Feb; 34(2):216-23. PubMed ID: 18093198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
    Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
    Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index and postoperative complications in kidney transplant recipients.
    Zrim S; Furlong T; Grace BS; Meade A
    Nephrology (Carlton); 2012 Aug; 17(6):582-7. PubMed ID: 22624682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine versus everolimus: effects on the glomerulus.
    Baas MC; Kers J; Florquin S; de Fijter JW; van der Heide JJ; van den Bergh Weerman MA; ten Berge IJ; Bemelman FJ
    Clin Transplant; 2013; 27(4):535-40. PubMed ID: 23795805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of recipient obesity on outcomes after renal transplantation.
    Cannon RM; Jones CM; Hughes MG; Eng M; Marvin MR
    Ann Surg; 2013 May; 257(5):978-84. PubMed ID: 23295317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial.
    Dantal J; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Quéré S; Di Giambattista F; Cassuto E;
    Transpl Int; 2010 Nov; 23(11):1084-93. PubMed ID: 20500493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
    Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
    Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant.
    Sampaio MS; Reddy PN; Kuo HT; Poommipanit N; Cho YW; Shah T; Bunnapradist S
    Transplantation; 2010 May; 89(9):1117-25. PubMed ID: 20164819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation.
    Derweesh IH; Ismail HR; Goldfarb DA; Araki M; Zhou L; Modlin C; Krishnamurthi V; Flechner SM; Novick AC
    BJU Int; 2008 Jun; 101(11):1415-9. PubMed ID: 18190623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus experience in heart transplantation.
    Aranda-Dios A; Lage E; Sobrino JM; Mogollón MV; Guisado A; Cabezón S; Hinojosa R; Hernández A; Ordóñez A
    Transplant Proc; 2006 Oct; 38(8):2547-9. PubMed ID: 17097997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.
    Rogers CC; Hanaway M; Alloway RR; Alexander JW; Boardman RE; Trofe J; Gupta M; Merchen T; Buell JF; Cardi M; Roy-Chaudhury P; Succop P; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):795-7. PubMed ID: 15848534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.